Pharmacogenomics at the Crossroads: Closing the Gap Between Genetic Evidence and Everyday Prescribing
Pharmacogenomic testing offers clinicians an unprecedented window into individual drug metabolism, yet widespread adoption in routine practice remains elusive. This article examines the structural, financial, and educational barriers that prevent CYP450 and TPMT testing from becoming standard of care—and offers practical frameworks for integrating genetic data into clinical workflows today.